The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Endocrine disruptors and prostate cancer risk
Open accessAbstract
There is increasing evidence both from epidemiology studies and animal models that specific endocrine-disrupting compounds may influence the development or progression of prostate cancer. In large part, these effects appear to be linked to interference with estrogen signaling, either through interacting with ERs or by influencing steroid metabolism and altering estrogen levels within the body. In humans, epidemiologic evidence links specific pesticides, PCBs and inorganic arsenic exposures to elevated prostate cancer risk. Studies in animal models also show augmentation of prostate carcinogenesis with several other environmental estrogenic compounds including cadmium, UV filters and BPA. Importantly, there appears to be heightened sensitivity of the prostate to these endocrine disruptors during the critical developmental windows including in utero and neonatal time points as well as during puberty. Thus infants and children may be considered a highly susceptible population for ED exposures and increased risk of prostate cancers with aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility
Anway, M. D., Cupp, A. S., Uzumcu, M., & Skinner, M. K. (2005) · Science · doi:10.1126/science.1108190 · Cited by 2,563
Exposure of the U.S. Population to Bisphenol A and 4- tertiary -Octylphenol: 2003–2004
Calafat, A. M., Ye, X., Wong, L.-Y., Reidy, J. A., & Needham, L. L. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10753 · Cited by 1,743
Ho, S.-M., Tang, W.-Y., Belmonte de Frausto, J., & Prins, G. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0516 · Cited by 796
Self-citationEndocrine activity and developmental toxicity of cosmetic UV filters—an update
Schlumpf, M., Schmid, P., Durrer, S., Conscience, M., Maerkel, K., Henseler, M., Gruetter, M., Herzog, I., Reolon, S., Ceccatelli, R., et al. (2004) · Toxicology · doi:10.1016/j.tox.2004.06.043 · Cited by 410
Cited by
Effect of Endocrine Disruptor Pesticides: A Review
Mnif, W., Hassine, A. I. H., Bouaziz, A., Bartegi, A., Thomas, O., & Roig, B. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8062265 · Cited by 1,012
Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action
De Coster, S., & van Larebeke, N. (2012) · Journal of Environmental and Public Health · doi:10.1155/2012/713696 · Cited by 617
Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk
Cizmas, L., Sharma, V. K., Gray, C. M., & McDonald, T. J. (2015) · Environmental Chemistry Letters · doi:10.1007/s10311-015-0524-4 · Cited by 413
Occurrence and toxicity of antimicrobial triclosan and by-products in the environment
Bedoux, G., Roig, B., Thomas, O., Dupont, V., & Le Bot, B. (2012) · Environmental Science and Pollution Research · doi:10.1007/s11356-011-0632-z · Cited by 376
Chlordecone Exposure and Risk of Prostate Cancer
Multigner, L., Ndong, J. R., Giusti, A., Romana, M., Delacroix-Maillard, H., Cordier, S., Jégou, B., Thome, J. P., & Blanchet, P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2153 · Cited by 362
Metadata
- Authors
- Prins, G. S.
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2008-05-22
- Volume
- 15
- Issue
- 3
- Pages
- 649-656
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2161544170
- Cited by
- 206
- References
- 5
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.